This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (5)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Joan Stephenson, PhD

JAMA. 2001;285:1281.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

New guidelines for treating patients infected with HIV advise clinicians to postpone prescribing potent combinations of antiretroviral drugs until later in the course of the disease than previously recommended. The advice to wait—except for patients presenting during acute HIV infection—reflects an enhanced appreciation of potential toxic effects resulting from long-term use of currently available anti-HIV medications.

The guidelines, which were released last month, are the work of the Panel on Clinical Practices for the Treatment of HIV Infection, a joint effort of the Department of Health and Human Services and the Henry J. Kaiser Family Foundation.

With the advent about 5 years ago of highly active antiretroviral therapy (HAART), many AIDS researchers embraced the idea that treating patients with HAART as soon as possible in the course of the infection was the best strategy for keeping HIV in check—and perhaps even eradicating the virus. Now, however, they . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?